KaloBios Pharma (KBIO) Could Drop 50% By Early Next Week: Tim Sykes

Tim Sykes thinks KaloBios Pharma (NASDAQ: KBIO) could drop 50% by early next week, according to the New York Post.

"I'm not saying it's going to crash Tuesday by noon, but I do expect a drop up to 50 percent by early next week" Sykes was quoted as saying.

KBIO has surged from pennies to $45.82 per share recently on an epic short squeeze after a Martin Shkreli group bought 70% of the outstanding shares and was appointed the new CEO, staving off a wind-down.

You May Also Be Interested In

• Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
• ClearPoint Neuro stock surges on peer's FDA approval plan
• Regenxbio shares jump after FDA agrees to reverse drug rejection